Jo Seung-Hee, Kim Dong Eun, Clocchiatti Andrea, Dotto G Paolo
Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA, USA.
Department of Dermatology, Harvard Medical School, Boston, MA, USA.
Oncotarget. 2016 Sep 13;7(37):58717-58727. doi: 10.18632/oncotarget.11227.
The Notch/CSL pathway plays an important role in skin homeostasis and carcinogenesis. CSL, the key effector of canonical Notch signaling endowed with an intrinsic transcription repressive function, suppresses stromal fibroblast senescence and Cancer Associated Fibroblast (CAF) activation through direct down-modulation of key effector genes. Interacting proteins that participate with CSL in this context are as yet to be identified. We report here that Programmed Cell Death 4 (PDCD4), a nuclear/cytoplasmic shuttling protein with multiple functions, associates with CSL and plays a similar role in suppressing dermal fibroblast senescence and CAF activation. Like CSL, PDCD4 is down-regulated in stromal fibroblasts of premalignant skin actinic keratosis (AKs) lesions and squamous cell carcinoma (SCC). While devoid of intrinsic DNA binding capability, PDCD4 is present at CSL binding sites of CAF marker genes as well as canonical Notch/CSL targets and suppresses expression of these genes in a fibroblast-specific manner. Thus, we propose that PDCD4 is part of the CSL repressive complex involved in negative control of stromal fibroblasts conversion into CAFs.
Notch/CSL信号通路在皮肤稳态和致癌过程中发挥着重要作用。CSL是经典Notch信号的关键效应因子,具有内在的转录抑制功能,它通过直接下调关键效应基因来抑制基质成纤维细胞衰老和癌症相关成纤维细胞(CAF)的激活。目前尚未确定在这种情况下与CSL相互作用的蛋白质。我们在此报告,程序性细胞死亡4(PDCD4)是一种具有多种功能的核/质穿梭蛋白,它与CSL相关,并在抑制真皮成纤维细胞衰老和CAF激活方面发挥类似作用。与CSL一样,PDCD4在前体皮肤光化性角化病(AKs)病变和鳞状细胞癌(SCC)的基质成纤维细胞中表达下调。虽然PDCD4缺乏内在的DNA结合能力,但它存在于CAF标记基因以及经典Notch/CSL靶标的CSL结合位点,并以成纤维细胞特异性方式抑制这些基因的表达。因此,我们提出PDCD4是参与负调控基质成纤维细胞转化为CAF的CSL抑制复合物的一部分。